EIC Internationalisation Services by inXso

Internationalisation services for EIC beneficiaries in the healthcare sector are provided by inXso in the framework of the EIC Ecosystem Partnerships and Co-Investment Support programme.

Due to the extensive network of experts operating in this area, the internationalisation services are focused profoundly on internationalisation in the US, the United Arab Emirates (UAE) and Asia, in particular Japan, South Korea, Malesia and Taiwan.

Tailored to meet the needs of EIC beneficiaries from the Health and medical care, Biotechnology and Health Tech, and Pharmaceuticals sectors, specifically such as:

• Medical Devices
• Implantable devices
• Digital Health
• Biopharmaceuticals, Biosimilars
• Cell & Gene Therapeutics
• Tissue Engineered Medicines
• Cell-based Medicines
• Combined ATMPs
• Integrated Drug Delivery Devices
• AI Integrated solutions

The service is directed to EIC pathfinder, EIC transition and EIC accelerator innovators in all TRL levels, henceforth beneficial to EIC beneficiaries in the research stage, spinout/startup, and scale-up.

inXso is partnering up with the European Innovation Council (EIC)

We’re delighted to share that inXso is now a new member of the European Innovation Council (EIC) network of organizations offering a set of EIC internationalisation services, aligning us with a vibrant community dedicated to supporting over 6,000+ innovations across Europe.

The Significance of Internationalisation Services

Companies in the healthcare sector are facing a solid push towards internationalisation in order to recover their investment and increase turnover as they operate in a particular niche market sector with a very limited domestic market.

At the same time, the companies are faced with forces constraining operations, as the industry involving implementation of medical research to improve health care and quality of life distinguishes itself from other high-technology sectors in that it has precise requirements when it comes to standardisation, quality management and regulatory compliance.

Emerging, breakthrough, and deep health technologies have a competitive edge much needed in accessing the health market, yet they may need more design aspects for overseas adaptation.

Concurrently, healthcare is inherently local with culture and nation-specific requirements to meet the safety design of the technology. Moreover, the purchasing decisions involve the need to understand how reimbursement works within the healthcare ecosystem.

inXso’s internationalisation services for EIC beneficiaries are tailored to address these barriers and accelerate market access from the HealthTech, MedTech, BioMedTech and Biotech & Pharma sectors.

Assessment of the Asian, the US and the UAE Markets for the Healthcare Sector

Build capacity for agile internationalisation through co-creation and co-design via individual training and coaching tailored to the needs of biomedical technology, medical technology, biotech and pharma industry.

The assessment will map the development process, considering its current TRL level and the value chain, including customers, competitors, public authorities, and other stakeholders relevant to the innovation’s development, approval, adaptation, and implementation.

Key features:

• Market-specific trends and business opportunities.
• Assessment of technological, market, financial, and clinical feasibility aspects.
• Market-specific requirements for the development and market access stage.

Benefits for EIC beneficiaries in i) research stage, ii) spinout/startup, iii) scale-up:

• Accelerate the R&D process by ensuring that the product meets multinational customers’ needs, processes and environment.
• Gain an understanding of how to adapt the product for multinational markets and implement the adaptation agilely in healthcare units, biomedical facilities or clinical environments.
• Gain an understanding of where the innovation may have the most need, its safety, efficacy, and cost-effectiveness in its user environment that, in turn, will give a competitive edge and marketing advantage.

The aim is to accelerate the innovation development process from its current TRL to market, create an agile approach and provide expertise to build a value chain that fits the ecosystem.

The service is directed to EIC pathfinder, EIC transition and EIC accelerator innovators by dedicated in-house or external experts depending on the target market via online, offline or hybrid models.

International Business Design Focused on Asia, the US, and the UAE

Build capacity for agile market entry and expansion through co-creation and co-design via individual training and coaching tailored to the needs of biomedical technology, medical technology, biotech, and pharma industry.

Considering its current TRL level and value chain, the guidance will navigate through innovative business models, commercialisation, Go2Market, and reimbursement strategies.

Key features:

• Business model optimisation with review & analysis.
• Business strategy optimisation with review & analysis.
• Commercialisation strategy optimisation with review & analysis.
• Regulatory gap analysis and reimbursement strategy.
• Market entry strategy analysis.
• Growth hacking.
• Distribution channels with cost estimation analysis.
• Strategic partnerships & agreement negotiation.

Benefits for EIC beneficiaries in i) research stage, ii) spinout/startup, iii) scale-up:

• Ensure your local market fit: Align policies with the local legislation and business practices.
• Secure revenues and stay ahead of competitors: Incorporate a feasible reimbursement strategy according to the local legislation.
• Accelerate market entry: Understand how the local health ecosystem works and align the go2market strategies accordingly.
• Clinical evaluations: Prepare in advance in case they are required for market accession. Also, use them in assessing the pricing model.
• Product success: Ensure reimbursement strategies optimally meet the target market regulatory requirement.

The service is directed to EIC pathfinder, EIC transition, and EIC accelerator innovators by dedicated in-house or external experts depending on the target market via online, offline, or hybrid models.

R&D Support for International Commercialisation for Healthcare Sector

Build capacity for inherent safe-by-design, standardisation, quality, and regulatory assurance through co-creation and co-design via individual training and coaching tailored to the needs of biomedical technology, medical technology, biotech, and the pharma industry.

The guidance will navigate the framework for complex health and medical care technologies, especially borderline cases, customised and personalised solutions that are challenging due to regulatory barriers, considering its current TRL level and the value chain.

Key features:

• Design of Experiments (DoE) and Human Factors Engineering (HFE)
• Proof of Concept (PoC) and prototyping.
• Safe-by-Design, and cross-cultural and cross-national design.
• Standardisation, Risk Management and QARA.
• Verification and Validation.
• Clinical design.

Benefits for EIC beneficiaries in i) research stage, ii) spinout/startup, iii) scale-up:

• Demonstrate the viability by early end-user feedback and check the manufacturability, cost, acceptability, accessibility, and market relevance of the final design.
• Incorporate requirements of the intended or potential market areas in the research and development phase, avoid costly redesign phases, and increase user safety of the innovation by considering multicultural design features.
• Incorporate target market-specific design features and carry out clinical evaluations to ensure regulatory compliance.

The aim is to accelerate innovations for health and medical care with high quality that are ready for the regulatory approval process and user-safe.

The service is directed to EIC pathfinder, EIC transition, and EIC accelerator innovators by dedicated in-house or external experts depending on the target market via online, offline, or hybrid models.

What is the EIC Ecosystem Partnerships and Co-Investment Support Programme?

The EIC Partners are selected under the EIC Ecosystem Partnerships and Co-Investment Support programme.

Launched in 2021, this programme has the goal of expanding the EIC Business Acceleration Services by addressing two of the greatest challenges for its innovators: access to specialised sector-focused services and attracting private investors.

The EIC Partners address the first need by providing:

• Standalone services such as workshops, training and matchmaking on topics that aren’t covered by BAS.
• Highly specific, niche services, such as the usage of specific laboratory equipment or technological due-diligence, and even relocation services and IPO coaching.
• Integration into partner’s accelerations, incubation, or venture building programmes, according to the technology stage and specificities of the innovators’ project.

On the co-investment front, beneficiaries are supported and trained to make the most of their interactions with investors and matched with the most relevant ones, both through events and direct introductions.
For more information, please refer to the EIC Ecosystem Partnerships and CoInvestment Support programme webpage.

About European Innovation Council

The European Innovation Council (EIC) has been established under Horizon Europe, with a budget of over €10 billion (2021-2027) to support game-changing innovations throughout their lifecycle, from early-stage research to market.

The EIC provides funding opportunities for companies in different stages of technological maturity through its instruments: EIC Pathfinder, EIC Transition and EIC Accelerator. These projects are selected through highly rigorous and competitive processes.

EIC Accelerator projects can receive up to €2.5M in grant funding, and are further eligible for up to €15M in direct equity investments from the EIC Fund. EIC innovators are also given access to the EIC Business Acceleration Services (BAS), which include coaching, mentoring and opportunities with corporates, procurers and investors.

inXso is glad to share our new partnership goals with BrainStormCorner, founded as a business think tank with global roots, born right next to Tampere University campus. BrainStormCorner is a versatile toolbox of business services and research commercialization, based on long international and multidisciplinary experience.

“While Finnish, we are extremely multilingual.”

With our common goals, inXso and BrainStormCorner will strive forwards to provide valuable insights for co-innovative solutions and international business development through upcoming collaboration offerings.

What to look forward to?

Through the partnership, both inXso and BrainStormCorner can provide a unique and in-depth insight into the international development of technology companies. We provide a platform for Finnish and foreign companies and start-ups. We help you to take the right steps towards building your business in Finland, or to develop your offering and expand abroad.

Our clients benefit from our multidisciplinary understanding of different technologies, as we speak both business and technology. We have long-standing international business insight in East Asia and Europe, which allows our clients to overcome barriers to market entry, identify business opportunities and provide practical solutions tailored to their needs.

Outstanding services currently available:

Companies and startups receive support for ideation, facilitation, engagement, project planning and hands-on experience for:

• Proof of Concept | ERC 
• EIC Accelerator 
• Horizon Europe 

For very early stage entrepreneurs:

This support system is available for very early stage entrepreneurs in Tampere region. There are no restrictions for the company’s field of activity. Tailored, intensive and valuable business development packages are available for those individuals who send an application and are accepted into the program: Pirkanmaan Yrittäjyysbuusti, Pirkanmaa Entrepreneurial Boost – BrainStormCorner 

Learn more at BrainStormCorner

About inXso

Born internationally, we are helping innovators open up new lines of research and technology that are disrupting existing healthcare ecosystems.

inXso provides services in the healthcare sector with three focus areas:

• Co-innovation & development
• International business development
• Innovation procurement support

Expo – a platform to open new business opportunities

Expos, trade fairs, and shows are a way to build business networks and search for partners that open new potential markets. It brings a lot of positive exposure for companies and their innovations, builds customer interest, and opens doors for collaborative projects along the life science and medical technology value chain. Especially for the healthcare ecosystem, industry-specific conferences and trade fairs are essential to bringing the newest forms of treatment and healthcare-related technology available to everyone.

Unfortunately in 2020, the Covid-19 pandemic caused worldwide lockdowns, and the many expos got whether canceled or postponed. After the initial chock, online platforms and virtual events were the next steps in efforts to keep the progress ongoing. In retrospect, some of the virtual expos were well-organized, while most were not all that well thought in terms of visitor and exhibitor friendliness.

Now in 2022, as the pandemic hits the third year, expos, trade fairs, and shows are slowly turning back to live events. But in many cases, they have also integrated hybrid models so that online participation is also a possibility, and hopefully with a little more thought on user-friendliness.

As the fastest growing market, Asia – Southeast Asia and the Asia Pacific specifically – is dependent on well-organized expos to enable healthcare ecosystem growth. One of the reasons why the region is hosting an incredible amount of different trade fairs and shows of different levels.

Asia-Pacific is the fastest growing market for life sciences and medical technology.

Expos not to miss in Asia 2022

Here is a list for the first half of the year 2022 of most interesting Expos, as it is an arduous task to figure out which to participate in the region and which are not that essential. Traditionally, Japan has been dominating in this domain, but South Korea has been shorten the lead by arranging life science expos on a larger scale in terms of visitors and exhibitors. On the other hand, in some developing countries, such as Malaysia and Indonesia, only one medical and hospital expo might be arranged that is worth consideration.

Always check the official webpage (link opens in new window) for details and specific info on how to participate in the event:

Use Desktop or Tablet to access the Expo details.

Apply for Reboot the Future – HealthTech Online Pitching to Venture Capital Investors with Slush China.

inXso provides a unique opportunity to apply for HealthTech Online Pitching in collaboration with Slush China in their forthcoming session for startup companies striving to innovate solutions to improve healthcare.

Slush China has invested time in organising a series of ‘Reboot the Future’ online pitching events revolving around several high-tech and deep-tech themes. The aim is to build a digital platform inspired by the digital leap and catalysed by the worldwide pandemic.

The first online event, open to global HealthTech startup teams, will take place on May 22nd in collaboration with Slush China, Nordic Hubs Health Capital Helsinki, and Upgraded to Venture Capital investors, corporate representatives, and startup communities. There will be significant participation from the Chinese Venture Capital investment companies focused on HealthTech, BioPharma, and BioMedTech, so if the Chinese healthcare market is in your company’s future interests, this event may just be worth investing some time in.

Reboot the Future is an excellent opportunity to seek investors’ insights from specialist investment groups such as ZhenFund, MicroPort, and GTJA Investment Groups and build collaboration towards Chinese markets. The jury will select for the final pitch the six best startups – three European or Global startups together with three Chinese startups – to represent their innovation to an audience of 400 entrepreneurs, investors, and company representatives around the world in a virtual event that is not only location-independent but easy to participate from your home office.

Take note of the important dates and apply for HealthTech Online Pitching for an exciting competition with other innovative HealthTech startups on the virtual platform.

Apply for Reboot the Future HealthTech Online Pitching to Venture Capital Investors with Slush China by scanning the code on the image above or using the link for registration.

Take a note on the important dates!

Why You Should Apply for HealthTech Online Pitching?

The Chinese healthcare market is the second largest in the world and, in many respects, quite unique. While the Chinese healthcare system is largely dependent on imported healthcare technology, the local market adapts fairly quickly to new technology.

On the other hand, they are interested in emerging and breakthrough healthcare technologies, and local investors and partners are keen to work with European and global companies in the sector.

However, success in the Chinese market requires specific knowledge of local regulations, reimbursement practicalities, intellectual property management, an adaptation of the business model, and an understanding of networking in Chinese cultural contexts.

The Reboot the Future Health Tech online pitching aims to connect European and global startup communities with their Chinese counterparts and promote collaboration in technology for healthcare. For the participants, it is an opportunity to gain feedback outside their ecosystems, improve their pitch for the global audience, seek investment opportunities, and, most importantly – build international partnerships towards the Chinese healthcare market. After the online pitching event, Health Tech Track will continue to help members improve investor and startup community relations in China.

Are you interested in applying for this unique opportunity? The application period starts on May 1st and ends on May 10th. To apply, please follow the registration link on the left panel or simply scan the code on the poster above.
The event will be held entirely in English, and a practical guide for participants will be sent once the application has been approved after a preliminary screening by the organisers.

Important dates:

1st May: Registration opens for Startups

10th May: End of registration for Startups

22nd May: Online pitching

Who may apply for the HeatlhTech Online Pitching?

The invitation to Reboot the future HealthTech online pitching is open for startup companies to apply globally, and we primarily focus on teams in incubators. However, it is open for any startup with innovation to improve healthcare. The innovation could provide solutions in form of digital health, biomedical technology, or medical devices, for example.

Do not hesitate to join the virtual community!

What are we Discussing?

In our series focusing on Health Tech in the Chinese market, inXso is organizing an interactive webinar, “What are the Key Points of Chinese Health Tech Initiatives—Join Discussion on May 29th,” together with Tampere HealthHUB.

The webinar will briefly discuss some of the key points and unique aspects of Chinese Health Tech initiatives and their implementation.

We will examine the concept of “Big Data” and its role in Health Tech development, market research, and marketing from a Chinese point of view. We will also provide an overview of the regulatory and IP landscape in China that European Health Tech companies should be aware of before entering the Chinese markets.

As a hierarchical society, China has its own perspectives on the R&D management structure that will influence decision-making and communication. We will see the advantages and disadvantages that this might bring to collaboration with Western companies.

When: May 29th 2020

Where: Online

Registration: Create your profile by May 27th 2020 by following the registration link.

We have created a Health Tech China Focus channel that will allow all participants to engage in the discussion.

We wish to make this an interactive discussion rather than just an informative webinar so participants may share their comments and questions in the chat room.

Welcome to join us!